title: Clinical Performance of a New Soluble CD14-Subtype Immunochromatographic Test for Whole Blood Compared with Chemiluminescent Enzyme Immunoassay: Use of Quantitative Soluble CD14-Subtype Immunochromatographic Tests for the Diagnosis of Sepsis.
abstract: We previously reported that a soluble CD14-subtype (sCD14-ST) immunochromatographic test (ICT) for plasma is more convenient than chemiluminescent enzyme immunoassay (CLEIA), but plasma separation makes bedside measurements difficult. We developed a new sCD14-ST ICT for whole blood and investigated whether quantitative determinations of sCD14-ST by ICT were useful for diagnosing sepsis and severe sepsis/septic shock. We studied 20 patients who fulfilled two or more systemic inflammatory response syndrome (SIRS) criteria and 32 patients who had been diagnosed with sepsis or severe sepsis/septic shock. Whole blood was collected on day 0 (on admission) and day 7, and the sCD14-ST concentration was quantitatively measured by CLEIA and ICT for whole blood. The patients' Acute Physiology and Chronic Health Evaluation (APACHE) II, Sequential Organ Failure Assessment (SOFA), and Mortality in Emergency Department Sepsis (MEDS) scores were also calculated. The cut-off values obtained by the quantitative measurements made by ICT were 464.5 pg/mL for sepsis and 762.7 pg/mL for severe sepsis/septic shock (P < 0.0001). A Bland-Altman plot showed that no fixed bias or proportional bias was detected between CLEIA and quantitative ICT for whole blood. sCD14-ST concentrations were significantly correlated with APACHE II, SOFA, and MEDS scores (P < 0.0001). These results suggest that the new sCD14-ST ICT for whole blood may be a useful tool for the convenient, rapid bedside diagnosis and treatment of sepsis.
authors.affiliation: Department of Critical Care Medicine, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Sato
authors.affiliation: Department of Critical Care Medicine, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
authors.forename: Gaku
authors.initials: G
authors.lastname: Takahashi
authors.affiliation: Department of Critical Care Medicine, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
authors.forename: Shigehiro
authors.initials: S
authors.lastname: Shibata
authors.affiliation: Department of Critical Care Medicine, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
authors.forename: Makoto
authors.initials: M
authors.lastname: Onodera
authors.affiliation: Department of Critical Care Medicine, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Suzuki
authors.affiliation: Department of Critical Care Medicine, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Inoue
authors.affiliation: Department of Critical Care Medicine, Iwate Medical University, Uchimaru, Morioka, Iwate, Japan.
authors.forename: Shigeatsu
authors.initials: S
authors.lastname: Endo
mesh_terms: D018806:APACHE; D000368:Aged; D016022:Case-Control Studies; D002846:Chromatography, Affinity / Q000379:methods*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D007159:Immunologic Tests / Q000379:methods; D018950:Lipopolysaccharide Receptors / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018805:Sepsis / Q000097:blood* / Q000175:diagnosis*; D012772:Shock, Septic / Q000097:blood / Q000175:diagnosis; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood* / Q000175:diagnosis*
chemical_list: D018950:Lipopolysaccharide Receptors